The aim of this CGM substudy of PRONTO-T1D was to compare glucose control as measured by CGM during treatment with URLi or lispro, when either was used in combination with basal insulin glargine or insulin degludec. This evidence concerns the gene INS and type 1 diabetes mellitus.